The Stanford Cardiac Surgical Arrhythmia Research Laboratory is a multidisciplinary, translational and basic science research laboratory that focuses on understanding the underlying electrophysiologic mechanisms of atrial fibrillation and translating this understanding into potential therapies for the treatment of atrial fibrillation.

Dr. Barna's lab studies how intricate control of gene expression and cell signaling is regulated on a minute-by-minute basis to give rise to the remarkable diversity of cell types and tissue morphology that form the living blueprints of developing organisms.

Dr. Breidenbach's research interests include e+e- colliding beam physics, with a particular interest in complete detector optimization and Si-W electromagnetic calorimeters.

Dr. Boyd's current research focus is on convex optimization applications in control, signal processing, and circuit design.

The goals of Dr. Nakauchi's work are to translate discoveries in basic research into practical medical applications.

Dr.Fathman's laboratory of molecular and cellular immunology is interested in mechanisms of T cell anergy and the pathophysiology and immunotherapy of preclinical animal models of autoimmune disease.

Dr. Narayan has built an independently funded “bedside-to-bench-to-bedside” translational research program focused on the mechanisms for human atrial fibrillation and life-threatening ventricular arrhythmias. This work led to the development of mapping techniques for fibrillation that use computational analysis in an attempt to circumvent the limitations of electrogram analysis by computationally reconstructing optical mapping.

Dr. Ioannidis's current research at Stanford covers a wide agenda, including meta-research, large-scale evidence, population health sciences and predictive medicine and health.

Dr. McCandliss studies developmental cognitive neuroscience, with an emphasis of questions of how the neural substrates of several cognitive abilities change via learning and education.

Dr. Porter is the director of pediatric epilepsy at Stanford Children's Health. Her clinical and transitional research focus is on understanding epileptogenesis and developing therapies to prevent epilepsy.